Skip to content
10-Q

Quarterly Report

Merck & Co., Inc. MRK

0001628280-26-029802

← back to feed
Filed
May 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 2.47B sh
Shares Diluted Q1 2026 · Mar 31, 2026 2.47B sh
Shares Diluted Q1 2026 · Mar 31, 2025 2.53B sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $874M
Stock Repurchased Q1 2026 · Mar 31, 2025 $1.16B
Dividends Paid Q1 2026 · Mar 31, 2026 $2.11B
Dividends Paid Q1 2026 · Mar 31, 2025 $2.05B
Capex Q1 2026 · Mar 31, 2026 $991M
Capex Q1 2026 · Mar 31, 2025 $1.33B
Operating Cash Flow Q1 2026 · Mar 31, 2026 $3.92B
Operating Cash Flow Q1 2026 · Mar 31, 2025 $2.5B
Long Term Debt Q1 2026 · Mar 31, 2026 $46.67B
Long Term Debt Q1 2026 · Dec 31, 2025 $46.75B
Short Term Debt Q1 2026 · Mar 31, 2026 $2.44B
Short Term Debt Q1 2026 · Dec 31, 2025 $2.59B
Cash And Equivalents Q1 2026 · Mar 31, 2026 $5.33B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $14.57B
Stockholders Equity Q1 2026 · Mar 31, 2026 $45.88B
Stockholders Equity Q1 2026 · Dec 31, 2025 $52.61B
Current Liabilities Q1 2026 · Mar 31, 2026 $26.95B
Current Liabilities Q1 2026 · Dec 31, 2025 $28.33B
Current Assets Q1 2026 · Mar 31, 2026 $35.02B
Current Assets Q1 2026 · Dec 31, 2025 $43.52B
Total Assets Q1 2026 · Mar 31, 2026 $128.69B
Total Assets Q1 2026 · Dec 31, 2025 $136.87B
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.72
Eps Diluted Q1 2026 · Mar 31, 2025 $2.01
Eps Basic Q1 2026 · Mar 31, 2026 −$1.72
Eps Basic Q1 2026 · Mar 31, 2025 $2.01
Sga Expense Q1 2026 · Mar 31, 2026 $2.7B
Sga Expense Q1 2026 · Mar 31, 2025 $2.55B
Rd Expense Q1 2026 · Mar 31, 2026 $12.59B
Rd Expense Q1 2026 · Mar 31, 2025 $3.62B
Net Income Q1 2026 · Mar 31, 2026 −$4.24B
Net Income Q1 2026 · Mar 31, 2025 $5.08B
Cost Of Revenue Q1 2026 · Mar 31, 2026 $4.2B
Cost Of Revenue Q1 2026 · Mar 31, 2025 $3.42B
Revenue Q1 2026 · Mar 31, 2026 $16.29B
Revenue Q1 2026 · Mar 31, 2025 $15.53B